Pediatric implications of heterozygous familial hypercholesterolemia

Authors	A. Wiegman
Supervisors	J.J.P. Kastelein H.S.A. Heymans
Cosupervisors	H.D. Bakker E.J.G. Sijbrands
Award date	01-07-2003
ISBN	9090170421 9789090170428
Number of pages	147
Organisations	Faculty of Medicine (AMC-UvA)
Document type	PhD thesis
Language	English
Downloads	Thesis Cover Titlepage Contents Chapter 1 Introduction and outline of this thesis Chapter 2 Family History and Cardiovascular Risk in Familial Hypercholesterolemia Data in more than 1000 children Chapter 3 The Apolipoprotein ε4 Allele Confers Additional Risk in Children with Familial Hypercholesterolemia Chapter 4 Effect of low-density lipoprotein receptor mutations on childhood lipid profile and parental risk of cardiovascular disease Chapter 5 The measurement of arterial wall thickness as a surrogate marker for atherosclerosis Chapter 6 Arterial Intima-Media Thickness in Childhood A study in familial hypercholesterolemia heterozygotes and their siblings Chapter 7 Pharmacokinetics of pravastatin in children with familial hypercholesterolemia Chapter 8 Statin Therapy in Hypercholesterolemic Children Long-term Efficacy and Safety Addendum Children with familial hypercholesterolemia express inflammatory markers. Statin effect on neopterin Summary Werkstuk van Karin, een bijna 10-jarige deelneemster aan ons onderzoek Samenvatting Dankwoord Curriculum Vitae Stellingen behorend bij het proefschrift Cover
Permalink to this page

Back

UvA-DARE